A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

Clinical trial NCT07624305 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07624305
Sponsor: AstraZeneca
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Renal Insufficiency, Chronic

Start date: 2026-09-01
Primary completion: 2030-07-01
Enrollment: 2800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.